Search

everythinglearnresearchcommunity

for

Search:↓

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.

Finasteride changes antioxidant enzyme expression, possibly affecting sperm protection in rats.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Herbal extracts may help hair grow and could be an alternative to synthetic hair loss treatments.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Hair from balding and non-balding areas regrows similarly on mice.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.